Megan Fuller

1.0k total citations
20 papers, 670 citations indexed

About

Megan Fuller is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Megan Fuller has authored 20 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Hematology. Recurrent topics in Megan Fuller's work include Acute Myeloid Leukemia Research (5 papers), MicroRNA in disease regulation (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). Megan Fuller is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), MicroRNA in disease regulation (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). Megan Fuller collaborates with scholars based in Canada, United States and Netherlands. Megan Fuller's co-authors include Aly Karsan, Linda Chang, Andrew I. Minchinton, Alastair H. Kyle, Joanna Węgrzyn, Pamela A. Hoodless, William W. Lockwood, Raj Chari, Stephen Lam and Ming‐Sound Tsao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Megan Fuller

19 papers receiving 666 citations

Peers

Countries citing papers authored by Megan Fuller

Since Specialization

Citations

This map shows the geographic impact of Megan Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Fuller more than expected).

Fields of papers citing papers by Megan Fuller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Fuller. The network helps show where Megan Fuller may publish in the future.

Co-authorship network of co-authors of Megan Fuller

This figure shows the co-authorship network connecting the top 25 collaborators of Megan Fuller. A scholar is included among the top collaborators of Megan Fuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan Fuller. Megan Fuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasm 2025 ·Leukemia ·(unknown), (unknown), Jihong Jiang, Vijay Suresh Akhade, Joshua Bridgers, Ryan J. Stubbins, Devendra Hiwase, Monika Kutyna, Onyee Chan, Rami S. Komrokji, Eric Padron, Yu Deng, Gary W. Cole, (unknown), Megan Fuller, (unknown), Aly Karsan	0
2	TIRAP drives myelosuppression through an Ifnγ–Hmgb1 axis that disrupts the endothelial niche in mice 2021 ·The Journal of Experimental Medicine ·(unknown), (unknown), Megan Fuller, (unknown), Jeremy Parker, (unknown), Linda Chang, (unknown), (unknown), Jenny Li, (unknown), Aly Karsan	17
3	Altered microRNA expression links IL6 and TNF-induced inflammaging with myeloid malignancy in humans and mice 2020 ·Blood ·(unknown), Joanna Węgrzyn, (unknown), Kieran O’Neill, (unknown), David J. H. F. Knapp, Jeremy Parker, Yu Deng, (unknown), Roderick Docking, Megan Fuller, Jenny Li, Mark Boldin, Connie J. Eaves, Martin Hirst, Aly Karsan	41
4	Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndrome 2020 ·Nature Cell Biology ·Sergio Martínez-Høyer, Yu Deng, Jeremy Parker, Jihong Jiang, Angela Mo, Roderick Docking, (unknown), Jenny Li, (unknown), Megan Fuller, Martin Jädersten, Austin Kulasekararaj, Luca Malcovati, Alan F. List, Eva Hellström‐Lindberg, Uwe Platzbecker, Aly Karsan	31
5	Fixation Effects on Variant Calling in a Clinical Resequencing Panel 2019 ·Journal of Molecular Diagnostics ·Jeremy Parker, (unknown), (unknown), (unknown), (unknown), Roderick Docking, Megan Fuller, Chen Zhou, Blair Walker, Douglas Filipenko, (unknown), Ahmer Karimuddin, P. Terry Phang, Manoj J. Raval, Carl J. Brown, Aly Karsan	4
6	Endothelial Sash1 Is Required for Lung Maturation through Nitric Oxide Signaling 2019 ·Cell Reports ·(unknown), Grigorios Paliouras, (unknown), (unknown), Megan Fuller, (unknown), Shauna Dauphinee, (unknown), Ping Xiang, (unknown), Andrew I. Minchinton, R. Keith Humphries, Pamela A. Hoodless, Jeremy Parker, James R. Wright, Aly Karsan	17
7	miR-143/145 differentially regulate hematopoietic stem and progenitor activity through suppression of canonical TGFβ signaling 2018 ·Nature Communications ·(unknown), Marion T.J. van den Bosch, Joanna Węgrzyn, Jeremy Parker, (unknown), (unknown), Linda Chang, Sergio Martínez-Høyer, Gianluigi Condorelli, Mark Boldin, Yu Deng, (unknown), Megan Fuller, Aly Karsan	36
8	Resistance to Lenalidomide in Del(5q) MDS Is Mediated By Inhibition of Drug-Induced Megakaryocytic Differentiation 2018 ·Blood ·Sergio Martínez-Høyer, Angela Mo, (unknown), Jihong Jiang, Roderick Docking, Jenny Li, Simon K. Chan, (unknown), Megan Fuller, Martin Jädersten, Eva Hellström‐Lindberg, Uwe Platzbecker, Jeremy Parker, Aly Karsan	1
9	APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner 2017 ·Gynecologic Oncology ·Yuyin Yi, Shu‐Huei Tsai, Jung‐Chien Cheng, Evan Y. Wang, Michael S. Anglesio, Dawn R. Cochrane, Megan Fuller, Ewan A. Gibb, Wei Wei, David G. Huntsman, Aly Karsan, Pamela A. Hoodless	33
10	A novel population of local pericyte precursor cells in tumor stroma that require Notch signaling for differentiation 2015 ·Microvascular Research ·Alexandre Patenaude, (unknown), (unknown), Fred Wong, (unknown), Alastair H. Kyle, (unknown), Megan Fuller, Jeremy Parker, Andrew I. Minchinton, Connie J. Eaves, Aly Karsan	12
11	Endothelial-Specific Notch Blockade Inhibits Vascular Function and Tumor Growth through an eNOS-Dependent Mechanism 2014 ·Cancer Research ·Alexandre Patenaude, Megan Fuller, Linda Chang, Fred Wong, Grigorios Paliouras, (unknown), Alastair H. Kyle, (unknown), Jennifer H.E. Baker, (unknown), (unknown), Andrew I. Minchinton, Aly Karsan	29
12	Loss of MiR-143 and MiR-145 Inhibits Hematopoietic Stem Cell Self-Renewal through Dysregulated TGFβ Signaling 2014 ·Blood ·(unknown), (unknown), (unknown), (unknown), (unknown), Megan Fuller, Aly Karsan	1
13	Activation of Non-Canonical Immune Signalling Pathways Drives Marrow Failure in a Murine Model of MDS 2014 ·Blood ·(unknown), Joanna Węgrzyn, Linda Chang, (unknown), Jeff Y. L. Lam, Megan Fuller, Aly Karsan	1
14	A Notch‐dependent transcriptional hierarchy promotes mesenchymal transdifferentiation in the cardiac cushion 2014 ·Developmental Dynamics ·Alex Chia Yu Chang, Victoria C. Garside, (unknown), (unknown), Pavle Vrljicak, (unknown), Megan Fuller, Gordon Robertson, Yongjun Zhao, Angela Tam, Steven J.M. Jones, Marco A. Marra, Pamela A. Hoodless, Aly Karsan	25
15	Notch-Dependent Regulation of the Ischemic Vasodilatory Response—Brief Report 2013 ·Arteriosclerosis Thrombosis and Vascular Biology ·Alex Chia Yu Chang, Alexandre Patenaude, Katherine Lu, Megan Fuller, Michelle Ly, Alastair H. Kyle, Saeid Golbidi, Yingjin Wang, Keith R. Walley, Andrew I. Minchinton, Ismail Laher, Aly Karsan	11
16	SASH1 Is a Scaffold Molecule in Endothelial TLR4 Signaling 2013 ·The Journal of Immunology ·Shauna Dauphinee, (unknown), (unknown), C. Paul Yang, Yoo-Jin Park, Megan Fuller, Josip Blonder, Timothy D. Veenstra, Aly Karsan	48
17	Differentiation of vascular smooth muscle cells from local precursors during embryonic and adult arteriogenesis requires Notch signaling 2012 ·Proceedings of the National Academy of Sciences ·Linda Chang, Michela Noseda, Michelle Higginson, Michelle Ly, Alexandre Patenaude, Megan Fuller, Alastair H. Kyle, Andrew I. Minchinton, Mira C. Puri, Daniel Dumont, Aly Karsan	61
18	Heterogeneity of breast cancer stem cells as evidenced with Notch‐dependent and Notch‐independent populations 2012 ·Cancer Medicine ·Nelson K.Y. Wong, Megan Fuller, Sandy Sung, Fred Wong, Aly Karsan	22
19	Notch Initiates the Endothelial-to-Mesenchymal Transition in the Atrioventricular Canal through Autocrine Activation of Soluble Guanylyl Cyclase 2011 ·Developmental Cell ·Alex Chia Yu Chang, Yang‐Xin Fu, Victoria C. Garside, Kyle Niessen, Linda Chang, Megan Fuller, Audi Setiadi, (unknown), Alastair H. Kyle, Andrew I. Minchinton, Marco A. Marra, Pamela A. Hoodless, Aly Karsan	134
20	TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer 2011 ·Journal of Clinical Investigation ·Daniel T. Starczynowski, William W. Lockwood, (unknown), Raj Chari, Joanna Węgrzyn, Megan Fuller, Ming‐Sound Tsao, Stephen Lam, Adi F. Gazdar, Wan L. Lam, Aly Karsan	146

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact